Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001708599-25-000067

Chief Scientific Officer sold 6,500 shares at $5.78 ($37,570)

  • Chief Scientific Officer acquired 6,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-06-30 Option exercise 10b5-1 +6,500 $0.06 $390 6,500 D: show line 1 in the form
Moreadith Randall Chief Scientific Officer 2025-06-30 Sale 10b5-1 −6,500 $5.78 $37,570 0 D: show line 2 in the form
Open-market sales · 6,500 sh · avg $5.78 · $37,570

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Moreadith Randall Chief Scientific Officer 2025-06-30 Option exercise · Stock Option (right to buy) 10b5-1 −6,500 514,686 D: show line 3 in the form
Loading xslF345X05/wk-form4_1751468419.xml…